Revolution Medicines logo

Director, Analytical Development

Revolution Medicines

Redwood City, CAHybridPosted 1 day ago$211,000 - $264,000/year
Full TimeDirector & AboveManufacturing & CMCBiotechnology
Original posting ↗

Summary

This leadership role will provide strategic and operational oversight for Analytical Development within the PDM organization, leading analytical strategies and execution to support Revolution Medicines' pipeline and clinical programs. Responsibilities include oversight of analytical method development, validation, transfer, release and stability testing, regulatory support, and management of external partners to enable phase appropriate development and commercialization readiness.

Job description

The Opportunity

This leadership role will provide strategic and operational oversight for Analytical Development within the PDM organization, leading analytical strategies and execution to support Revolution Medicines' pipeline and clinical programs. Responsibilities include oversight of analytical method development, validation, transfer, release and stability testing, regulatory support, and management of external partners to enable phase appropriate development and commercialization readiness.

Responsibilities

  • Provide strategic and organizational leadership for analytical development activities supporting small molecule API and drug product development, including oversight of phase appropriate control strategies, specification setting, analytical lifecycle management, and overall CMC analytical strategy.
  • Lead and oversee analytical development execution across internal and external teams to support the development, characterization, and manufacturing of API and drug product, while actively contributing to cross functional PDM project teams.
  • Provide strategic guidance and oversight for regulatory submission activities, including authoring and review Quality sections of regulatory submissions, and leading responses to regulatory queries.
  • Establish and drive analytical strategies, technology selection, and operational execution through effective management of CDMOs, CROs, and contract laboratories, with accountability for quality, timelines, risk management, and delivery.
  • Provide leadership oversight for preparation, review, and approval of analytical protocols, reports, specifications, investigations, and technical documentation to ensure scientific excellence, regulatory compliance, and inspection readiness.
  • Build strong cross functional partnerships and influence across Drug Product, Drug Substance, Regulatory Affairs, QA, Project Management, Medicinal Chemistry, DMPK, Toxicology and senior leadership teams to drive strategic decision making and achievement of program and organizational goals.

Required Skills, Experience and Education

  • PhD preferred (minimum MS) in Analytical Chemistry, Organic Chemistry, or a related scientific discipline.
  • 10+ years of progressive leadership experience in analytical development within the pharmaceutical or biotechnology industry.
  • Proven ability to lead cross functional teams, influence organizational decision making, and drive execution of complex development strategies in a matrix environment.
  • Extensive strategic and operational leadership experience overseeing analytical activities across small molecule drug development, with strong preference for late phase development, regulatory approval, and commercialization readiness.
  • Excellent communication, collaboration, people leadership, and stakeholder management skills.
  • Deep understanding of CMC strategies and analytical enablement for small molecule development programs.
  • Demonstrated leadership experience managing external partners, including CROs and CDMOs, to ensure high-quality deliverables and program execution.
  • Strong knowledge of global regulatory requirements and experience supporting regulatory submissions, including INDs, IMPDs, NDAs, and/or MAAs.
  • In-depth understanding of ICH guidelines, GMP regulations, and current industry best practices related to analytical development and quality.
  • Strong strategic thinking and innovation mindset with the ability to independently evaluate complex issues, identify risks, and implement effective solutions.
  • Ability to prioritize and lead multiple initiatives in a fast paced, dynamic, and highly collaborative environment.

Preferred Skills

  • Experience leveraging AI tools to streamline workflows, automate repetitive tasks, and enhance team productivity.
  • Experience in analytical method development for biologics.

Requirements

  • PhD preferred (minimum MS) in Analytical Chemistry, Organic Chemistry, or a related scientific discipline
  • 10+ years of progressive leadership experience in analytical development within the pharmaceutical or biotechnology industry
  • Proven ability to lead cross functional teams, influence organizational decision making, and drive execution of complex development strategies in a matrix environment
  • Extensive strategic and operational leadership experience overseeing analytical activities across small molecule drug development, with strong preference for late phase development, regulatory approval, and commercialization readiness
  • Excellent communication, collaboration, people leadership, and stakeholder management skills
  • Deep understanding of CMC strategies and analytical enablement for small molecule development programs
  • Demonstrated leadership experience managing external partners, including CROs and CDMOs, to ensure high-quality deliverables and program execution
  • Strong knowledge of global regulatory requirements and experience supporting regulatory submissions, including INDs, IMPDs, NDAs, and/or MAAs
  • In-depth understanding of ICH guidelines, GMP regulations, and current industry best practices related to analytical development and quality
  • Strong strategic thinking and innovation mindset with the ability to independently evaluate complex issues, identify risks, and implement effective solutions
  • Ability to prioritize and lead multiple initiatives in a fast paced, dynamic, and highly collaborative environment
  • Experience leveraging AI tools to streamline workflows, automate repetitive tasks, and enhance team productivity
  • Experience in analytical method development for biologics

Benefits

  • Competitive Cash Compensation
  • Equity Awards
  • Health Benefits
  • Learning & Development Opportunities

Company overview

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The company is pioneering a new class of therapeutics that target oncogenic RAS mutations, which are among the most common drivers of human cancers. Revolution Medicines employs a unique approach to drug discovery, leveraging deep insights into RAS biology to develop small molecule inhibitors that can address previously undruggable targets. Their pipeline includes multiple clinical-stage candidates designed to inhibit various RAS pathway mutations, with a particular focus on KRAS G12C and other RAS variants. The company's scientific platform combines structural biology, medicinal chemistry, and computational approaches to design highly selective inhibitors. Revolution Medicines aims to transform cancer treatment by developing therapies that can overcome resistance mechanisms and provide durable clinical benefits for patients with RAS-driven malignancies. Their research represents a significant advancement in the field of targeted cancer therapy, addressing one of the most challenging areas in oncology drug development.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.